AbbVie Inc. v. Hetero USA, Inc. et al
1:25-cv-00190 | Delaware District Court
Interested in this case?
Request a Demo Track this case, and find millions of cases like it, let us show you how.Filing Date | # | Docket Text |
---|---|---|
3/14/2025 | SO ORDERED, -District Court Pro Hac Vice Fee - 03 Attorneys Credit Card Payment | |
3/14/2025 | 10 | Appear Pro Hac Vice |
2/25/2025 | 9 | Waiver of Service Executed - 60 day ddl |
2/25/2025 | 8 | Waiver of Service Executed - 60 day ddl |
2/25/2025 | 7 | Waiver of Service Executed - 60 day ddl |
2/19/2025 | Case Assigned to Judge Maryellen Noreika. Please include the initials of the Judge (MN) after the case number on all documents filed. (nms) (Entered: 02/19/2025) | |
2/18/2025 | CORRECTING ENTRY: The main document and attachment documents at D.I. 6 have been modified and replaced to reflect the correct day of issuance. (cdd) (Entered: 02/18/2025) | |
2/14/2025 | 6 | Summons Issued as to Hetero Labs Limited on 2/18/2025; Hetero Labs Limited Unit-V on 2/18/2025; Hetero USA, Inc. on 2/18/2025; Hoster Labs Private Limited on 2/18/2025. (Attachments: # 1 Summons Issued, # 2 Summons Issued, # 3 Summons Issued)(cdd). (Entered: 02/18/2025) |
2/14/2025 | 5 | Disclosure Statement pursuant to Rule 7.1: No Parents or Affiliates Listed filed by AbbVie Inc. (cdd) (Entered: 02/18/2025) |
2/14/2025 | 4 | Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 11,607,411 B2; 11,564,922 B2. (cdd) (Entered: 02/18/2025) |
2/14/2025 | 3 | Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 2/6/2025. Date of Expiration of Patent: 3/9/2038.Thirty Month Stay Deadline: Not earlier than 8/6/2027. (cdd) Modified on 2/18/2025 (nms). (Entered: 02/18/2025) |
2/14/2025 | 2 | Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (cdd) (Entered: 02/18/2025) |
2/14/2025 | 1 | COMPLAINT against Hetero Labs Limited, Hetero Labs Limited Unit-V, Hetero USA, Inc., Hoster Labs Private Limited (Filing fee $ 405, receipt number ADEDC-4615717) - filed by AbbVie Inc.. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Civil Cover Sheet)(cdd) (Entered: 02/18/2025) |